SCHEMBL20715289

SCHEMBL20715289

CC[C@H](C(=O)NC(C)C)N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ FAAH O00519 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ EPHX1 P07099 2/20 0.33
▸ XIAP P98170 1/20 0.33
▸ MMP1 P03956 2/20 0.32
▸ MMP2 P08253 2/20 0.32
▸ MME P08473 1/20 0.32
▸ ACE P12821 1/20 0.32
▸ CPA1 P15085 1/20 0.32
▸ ACE2 Q9BYF1 1/20 0.32
▸ MMP3 P08254 1/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ MMP9 P14780 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1801850 0.77 HDAC8 (0.43) TSHRUSP2MMP1MMP2MMP3
SCHEMBL21158803 0.77 USP2 (0.39) TSHRUSP2MEN1KMT2ACA1
SCHEMBL13609165 0.77 TSHR (0.54) ALDH1A1TSHRUSP2MEN1KMT2A
SCHEMBL20715292 0.76 TSHR (0.43) ALDH1A1TSHRUSP2MEN1KMT2A
SCHEMBL8121888 0.72 USP2 (0.35) TSHRUSP2
SCHEMBL13876693 0.72 ALDH1A1 (0.42) ALDH1A1TSHRUSP2MEN1KMT2A
SCHEMBL13671565 0.72 CA12 (0.37) ALDH1A1TSHRMEN1KMT2AFAAH
SCHEMBL10031629 0.72 ALDH1A1 (0.42) ALDH1A1TSHRUSP2MEN1KMT2A
SCHEMBL115663 0.72 ALDH1A1 (0.42) ALDH1A1TSHRUSP2MEN1KMT2A
SCHEMBL18762848 0.71 USP2 (0.35) TSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019027960-A1 PYRAZOLO AND TRIAZOLO BICYCLIC COMPOUNDS AS JAK KINASE INHIBITORS THERAVANCE BIOPHARMA R&D IP, LLC (US) 2019-02-07 — — WO disclosed
Send feedback